MRI-defined vascular depression: A review of the construct

International Journal of Geriatric Psychiatry

Volumn 26, Issue 11, 2011, Pages 1101-1108

  Culang Reinlieb, Michelle E ^a,b   Johnert, Lauren C ^a,b   Brickman, Adam M ^c,d   Steffens, David C ^e   Garcon, Ernst ^d   Sneed, Joel R ^b,d,f  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e DUKE UNIVERSITY   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

antidepressant response; cerebrovascular disease; deep white matter lesions; executive dysfunction; late life depression; vascular depression

Indexed keywords

ANTIDEPRESSANT AGENT; NIMODIPINE;

CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; HUMAN; INFORMATION RETRIEVAL; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITATIVE VALIDITY; REVIEW; VASCULAR DEPRESSION;

CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; HUMANS; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS;

EID: 80054993337     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2668     Document Type: Review

References (97)

1. Alexopoulos G, Kiosses DN,., Heo M, et al,. 2005. Executive dysfunction and the course of geriatric depression. Biol Psychiatr 58: 204-210.
2. Alexopoulos GS,. 2001. " The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? Am J Geriatr Psychiatr 9: 22-29.
3. Alexopoulos GS,. 2002. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatr 10: 687-695.
4. Alexopoulos GS,. 2006. The vascular depression hypothesis: 10 years later. Biol Psychiatr 60: 1304-1305.
5. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO,. 2002a. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatr 159: 1929-1932.
6. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML,. 2002b. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatr 10: 98-106.
7. Alexopoulos GS, Meyers BS, Young RC, et al,. 1997a. 'Vascular depression' hypothesis. Arch Gen Psychiatr 54: 915-922.
8. Alexopoulos GS, Meyers BS, Young RC, et al,. 1997b. 'Vascular depression' hypothesis [see comment]. Arch Gen Psychiatr 54: 915-922.
9. Alexopoulos GS, Meyers BS, Young RC, et al,. 1997c. Clinically defined vascular depression. Am J Psychiatr 154: 562-565.
10. Alexopoulos GS, Meyers BS, Young RC, et al,. 2000. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatr 57: 285-290.
11. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al,. 2008. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatr 165: 238-244.
12. Alexopoulos GS, Raue P, Arean P,. 2003. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatr 11: 46-52.
13. Artero S, Tiemeier H, Prins ND, Sabatier R, Breteler MMB, Ritchie K,. 2004. Neuroanatomical localization and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg 75: 1304-1308.
14. Assareh A, Mather KA, Schofield PR, Kwok JB, Sachdev PS,. 2010. The genetics of white matter lesions. CNS Neurosci Ther Epub ahead of print.
15. Atwood LD, Wolf PA, Heard-Costa NL, et al,. 2004. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 35: 1609-1613.
16. Bae JN, MacFall JR, Krishnan KR, Payne ME, Steffens DC, Taylor WD,. 2006. Dorsolateral prefrontal cortex and anterior cingulated cortex white matter alterations in late-life depression. Biol Psychiatr 60: 1356-1363.
17. Baldwin R, Jeffries S, Jackson A, et al,. 2004. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 34: 125-136.
18. Brickman AM, Reitz C, Luchsinger LJA, et al,. 2010. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 67: 564-569.
19. Butters MA, Bhalla RK, Mulsant BH, et al,. 2004. Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression. Am J Geriatr Psychiatr 12: 387-394.
20. Carmelli D, Reed T, DeCarli C,. 2002. A bivariate genetic analysis of cerebral white matter hyperintensities and cognitive performance in elderly male twins. Neurobiol Aging 23: 413-420.
21. Coffey CE, Figiel GS, Djang WT, Weiner RD,. 1990. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatr 147: 187-189.
22. Coffey CE, Wilkinson WE, Weiner RD, et al,. 1993. Quantitativec cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatr 50: 7-16.
23. Culang M, Sneed J, Keilp J, et al,. 2009. Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatr 17: 881-888.
24. de Groot JC, de Leeuw FE, Oudkerk M, et al,. 2000. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatr 57: 1071-1076.
25. de Groot MH, Nolen WA, Huijsman AM, Bouvy PF,. 1996. Lateralized neuropsychological functioning in depressive patients before and after drug therapy. Biol Psychiatr 40: 1282-1287.
26. Debette S, Markus HS,. 2010. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. Br Med J 341: c3666.
27. Fabre I, Galinowski A, Oppenheim C, et al,. 2004. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial. Int J Geriatr Psychiatr 19: 833-842.
28. Firbank MJ, Lloyd AJ, Ferrier N, O'brien JT,. 2004. A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatr 12: 606-612.
29. Fujikawa T, Yamawaki S, Touhouda Y,. 1993. Incidence of silent cerebral infarction in patients with major depression. Stroke 24: 1631-1634.
30. Greenwald BS, Kramer-Ginsberg E, Krishnan KR, et al,. 1998. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 29: 613-617.
31. Gunning-Dixon FM, Walton M, Cheng J, et al,. 2010. MRI signal hyperintensities and treatment remission of geriatric depression. J Affect Disord 126: 395-401.
32. Hannestad J, Taylor WD, McQuoid DR, et al,. 2006. White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatr 21: 1193-1198.
33. Herrmann LL, LeMasurier M, Ebmeier KP,. 2007. White matter hyperintensities in late life depression: a systematic review. J neurol Neurosurg 37: 1693-1702.
34. Hickie I, Scott E, Mitchell P, et al,. 1995. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatr 37: 151-160.
35. Idaka T, Nakajima T, Kawamoto K, et al,. 1996. Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients. Eur Neurol 36: 293-299.
36. Janssen J, Pol HE, Schnack HG, et al,. 2007. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatr 22: 468-474.
37. Kalayam B, Alexopoulos GS,. 1999. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatr 56: 713-718.
38. Kales HC, Maixner DF, Mellow AM,. 2005. Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatr 13: 88-98.
39. Kim B, Lee D, Lee D, et al,. (in press). The role of vascular risk factors in the development of Depression with Executive Dysfunction (DED) syndrome among an elderly community sample. Am J Geriatr Psychiatr.
40. Kim JM, Stewart R, Shin IS, Yoon JS,. 2004. Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatr 185: 102-107.
41. Kiosses DN, Teri L, Velligan DI, Alexopoulos GS,. 2010. A home-delivered intervention for depressed, cognitively impaired, disabled elders. Int J Geriatr Psychiatr Epub ahead of print.
42. Krishnan KR,. 1993. Neuroanatomic substrates of depression in the elderly. J Geriatr Psychiatr Neurol 6: 39-58.
43. Krishnan KR, Hays JC, Blazer DG,. 1997a. MRI-defined vascular depression. Am J Psychiatr 154: 497-501.
44. Krishnan KR, McDonald WM,. 1995. Arteriosclerotic depression. Med Hypotheses 44: 111-115.
45. Krishnan KR, Taylor WD, McQuoid DR, et al,. 2004. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatr 55: 390-397.
46. Krishnan KRR, Hays JC, Blazer DG,. 1997b. MRI-defined vascular depression. Am J Psychiatr 154: 497-501.
47. Krishnan KRR, Hays JC, George LK, Blazer DG,. 1998. Six-month outcomes for MRI-related vascular depression. Depression Anxiety 8: 142-146.
48. Krishnan MS, O'Brien JT, Firbank MJ, et al. 2006. Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatr 21: 983-989.
49. Lai T, Payne ME, Byrum CE, Steffens DC, Krishnan KR,. 2000. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatr 48: 971-975.
50. Lesser I, Boone K, Mehringer C, et al,. 1996. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatr 153: 1280-1287.
51. Lyness JM, Caine ED, Cox C, et al,. 1998. Cerebrovascular risk factors and later-life major depression. Testing a small-vessel brain disease model. Am J Geriatr Psychiatr 6: 5-13.
52. Lyness JM, Caine ED, King DA, et al,. 1999. Cerebrovascular risk factors and depression in older primary care patients: testing a vascular brain disease model of depression. Am J Geriatr Psychiatr 7: 252-258.
53. MacFall JR, Payne ME, Provenzale JE, Krishnan KR,. 2001. Medial orbital frontal lesions in late-onset depression. Biol Psychiatr 49: 803-806.
54. Modrego PJ, Ferrandez J,. 2004. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 61: 1290-1293.
55. Morimoto S, Gunning FM, Murphy CF, et al,. (in press). Executive function and short-term remission of geriatric depression: the role of semantic strategy. Am J Geriatr Psychiatr.
56. Murphy CF, Gunning-Dixon FM, Hoptman MJ, et al,. 2007. White-matter integrity predicts stroop performance in patients with geriatric depression. Biol Psychiatr 61: 1007-1010.
57. Murphy GF, Alexopoulos GS,. 2006. Attention network dysfunction and treatment of response of geriatric depression. J Clin Exp Neuropsychol 28: 96-100.
58. Naarding P, Tiemeier H, Breteler MMB, et al,. 2007. Clinically defined vascular depression in the general population. Psychol Med 37: 383-392.
59. Narushima K, McCormick LM, Yamada T, Thatcher RW, Robinson RG,. 2010. Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatr Clin Neurosci 22: 75-84.
60. Navarro V, Gasto C, Lomena F, et al,. 2004. Prognostic value of frontal functional neuroimaging in late-onset severe major depression. Br J Psychiatr 184: 306-311.
61. Nebes RD, Vora IJ, Meltzer CC, et al,. 2001. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatr 158: 878-884.
62. Nobuhara K, Okugawa G, Sugimoto T, et al,. 2006. Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study. J Neurol Neurosurg Psychiatr 77: 120-122.
63. O'Brien J, Desmond P, Ames D, et al,. 1996. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatr 168: 477-485.
64. Paranthaman R, Greenstein AS, Burns AS, et al,. 2010. Vascular function in older adults with depressive disorder. Biol Psychiatr 68: 133-139.
65. Patankar TF, Mitra D, Varma A, et al,. 2005. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. Am J Neuroradiol 26: 1512-1520.
66. Patankar TF, Mitra D, Varma A, et al,. 2007. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord 97: 265-270.
67. Pugh KG, Lipsitz LA,. 2002. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 23: 421-431.
68. Richardson J, Kerr SR, Shaw F, et al,. 2009. A study of orthostatic hypotension in late-life depression. Am J Geriatr Psychiatr 17: 996-999.
69. Rouhl RP, van Oostenbrugge RJ, Knottnerus IL, Staals JE, Lodder J,. 2008. Virchow-Robin spaces relate to cerebral small vessel disease severity. J Neurol 255: 692-696.
70. Saghafi R, Brown C, Butters MA, et al,. 2007. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatr 22: 1141-1146.
71. Salloway S, Correia S, Boyle P, et al,. 2002. MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. J Neurol Sci 203-204, 227-233.
72. Salloway S, Malloy P, Kohn R, et al,. 1996. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 46: 1567-1574.
73. Schweitzer I, Tuckwell V, O'Brien J, Ames D,. 2002. Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatr 17: 997-1005.
74. Sheline YI, Pieper CF, Barch DM, et al,. 2010. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatr 67: 277-285.
75. Simpson S, Baldwin RC, Jackson A, Burns A S,., 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological, and neuroradiological findings in late-life depression. Psychol Med 28: 1015-1026.
76. Sneed JR, Culang-Reinlieb ME,. (in press). The vascular depression hypothesis: an update. Am J Geriatr Psychiatr.
77. Sneed JR, Kasen S, Cohen P,. 2007a. Early-life risk factors for late-onset depression. Int J Geriatr Psychiatr 22: 663-667.
78. Sneed JR, Rindskopf D, Steffens DC, Krishnan KR, Roose SP,. 2008. The vascular depression subtype: Evidence of internal validity. Biol Psychiatr 64: 491-497.
79. Sneed JR, Roose SP, Keilp JG, et al,. 2007b. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatr 15: 553-563.
80. Sneed JR, Roose SP, Sackeim HA,. 2006. Vascular depression: a distinct diagnostic entity? Biol Psychiatr 60: 1295-1298.
81. Steffens DC,. 2004. Establishing diagnostic criteria for vascular depression. J Neurol Sci 226: 59-62.
82. Steffens DC, Krishnan KR,. 1998. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatr 43: 705-712.
83. Steffens DC, McQuoid DR, Welsh-Bohmer KA, Krishnan KR,. 2003. Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls. Neuropsychopharmacology 28: 2179-2183.
84. Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG,. 2001. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int J Geriatr Psychiatr 16: 254-260.
85. Taragano FE, Bagnatti P, Allegri RF,. 2005. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression ". Int J Psychogeriatr 17: 487-498.
86. Taylor WD, MacFall JR, Payne ME, et al,. 2004. Late-life depresion and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatr 161: 1293-1296.
87. Taylor WD, MacFall JR, Payne ME, et al,. 2007. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med 37: 1763-1773.
88. Taylor WD, MacFall JR, Steffens DC, et al,. 2003a. Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuro-psychopharmacol Biol Psychiatr 27: 539-544.
89. Taylor WD, Steffens DC, Krishnan KR,. 2006. Psychiatric disease in the twenty-first century: the case for subcortical ischemic depression. Biol Psychiatr 60: 1299-1303.
90. Taylor WD, Steffens DC, MacFall JR, et al,. 2003b. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatr 60: 1090-1096.
91. Thomas AJ, Ferrier IN, Kalaria RN, et al,. 2000. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatr 157: 1682-1684.
92. Thomas AJ, O'Brien JT, Davis S, et al,. 2002. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatr 59: 785-792.
93. Thomas AJ, Perry R, Kalaria RN, et al,. 2003. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatr 18: 7-13.
94. Tiemeier H, van Dijck W, Hofman A, et al,. 2004. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatr 61: 369-376.
95. Turner ST, Jack CR, Fornage M, et al,. 2004. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 43: 483-487.
96. van Straaten EC, Fazekas F, Rostrup E, et al,. 2006. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37: 836-840.
97. Wallin A, Fladby T,. 2010. Do white matter hyperintensities on MRI matter clinically? Br Med J 341: c3400.